Skip to main content

Table 4 Factors associated with HPV vaccine uptake, multimodel averaging approach (France, 2016)

From: Vaccine hesitancy about the HPV vaccine among French young women and their parents: a telephone survey

 

Partial R2

aOR#[95% CI]

Weight*

Evidence

Rank

Clusters

0.13

    

Cluster 1

 

1

1.000

Very strong

1

Cluster 2

 

0.15 [0.11;0.20]

Cluster 3

 

0.49 [0.40;0.61]

Cluster 4

 

0.27 [0.17;0.42]

Gender/age

1.000

Very strong

2

 Young women

  15–19 years old

 

1

  20–25 years old

 

1.98 [1.50;2.61]

Parents of young women:

 Women

0.07

 

  26–45 years old

 

0.60 [0.45;0.80]

  > 46 years old

 

0.79 [0.57;1.09]

Men

 25–45 years old

 

0.41 [0.27;0.62]

 > 45 years old

 

0.65 [0.46;0.92]

Favorable to vaccination in general:

1.000

Very strong

3

 Absolutely/Somewhat

0.02

1

 Not really/Not at all

 

2.27 [1.73;2.96]

 Educational level

  

0.580

Weak

4

 < High-school

0.00

1

 High-school

 

1.18 [0.94;1.49]

 1–3 years completed at university

 

1.09 [0.83;1.42]

 > 3 years completed at university

 

0.76 [0.54;1.07]

 Household Income

0.00

 

0.190

None

5

 Low

 

1

 Medium

 

0.83 [0.66;1.04]

 High

 

0.98 [0.75;1.28]

 no answer

 

0.89 [0.61;1.31]

  1. *According to Viallefont’s classification [0–0.5]: no evidence; [0.5–0.75]: weak evidence; [0.75–0.90]: positive evidence; [0.95–0.99]: strong evidence; [0.99–1]: very strong evidence
  2. # adjusted odds ratio